The trend for the timing of initial marketing authorization applications (MAAs) to be less predictable is slowly reversing ...
EMA details rapid procedures for COVID-19 products The European Medicines Agency (EMA) on Monday laid out its tools for expediting the development and approval of medicinal products for coronavirus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results